Related Experiment Video
Updated: May 2, 2026

06:31
Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
8.2K
Utility of patch testing for patients with drug eruption.
1Division of Dermatology, Showa University Fujigaoka Hospital, Kanagawa, Japan.
Clinical and Experimental Dermatology
|March 19, 2014
Summary
Patch testing is a safer alternative to oral provocation for identifying drug eruption causes. Positive results were most common with contrast media and antiepileptics, suggesting patch testing is useful for these specific drug classes.
Area of Science:
- Dermatology
- Clinical Immunology
- Pharmacology
Background:
- Drug eruptions are common adverse reactions to medications.
- Patch testing is a less dangerous alternative to oral provocation for identifying causative agents.
- The diagnostic utility of patch testing for drug eruptions remains debated.
Purpose of the Study:
- To determine the rates of positive patch test results in patients with drug eruptions.
- To analyze these rates based on the suspected causative drugs and clinical presentation.
- To assess the overall usefulness of patch testing in diagnosing drug-induced skin reactions.
Main Methods:
- Analysis of data from 444 patients tested for drug eruption between 1990 and 2010.
- Patch tests applied to the back under occlusion for 2 days.
- Results interpreted using the International Contact Dermatitis Research Group (ICDRG) scoring system.
Main Results:
- 100 out of 444 patients (22.4%) showed positive patch test reactions.
- Positive rates were 23.6% for maculopapular eruption and 20.0% for fixed drug eruption.
- Most positive reactions were to contrast media (41.1%) and central nervous system drugs (28.6%), particularly antiepileptics.
Conclusions:
- Positive patch test rates are influenced more by the specific causative drug than the clinical features of the eruption.
- Patch testing demonstrates utility when contrast media or antiepileptics are suspected.
- Further validation, standardization of materials and methods, and clear guidelines are necessary for optimal use of patch testing in drug eruptions.
Related Concept Videos
Drug Toxicity: Allergic Reactions
209
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
209
Allergic Drug Reactions
1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Patch Clamp
6.0K
Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
6.0K
Transdermal Drug Delivery Systems
233
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
233
Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Drug Excretion: Miscellaneous Routes
514
Drug excretion involves various organs, including the liver, intestines, skin, and eyes. In the case of drugs or toxins, they can be actively secreted into bile by transporters in the hepatocyte's canalicular membrane. These substances enter the GI tract during digestion and may be reabsorbed into the body from the intestine. This process, known as enterohepatic recycling, can significantly prolong the presence and effects of a substance in the body. To interrupt this cycle, specific...
514

